In this week’s issue:
- Cystic Fibrosis Foundation – Pilot and Feasibility Awards
- Lupus Foundation of America – Career Development Award
- Cystinosis Research Foundation – Call for Research Proposals and Postdoctoral Research Fellowships
- US Department of Defense – Ovarian Cancer Research Program
Awards and Honours:
- Health Research Foundation – Medal of Honour
- UBC Centre for Blood Research Seminar Series – Dr. Sidney Strickland: Connections between Alzheimer’s disease and the cerebrovascular system
- UBC Department of Family Practice – Research Development Workshop
Deadline: April 6, 2016 or September 14, 2016
The mission of the Cystic Fibrosis Foundation is to cure cystic fibrosis and to provide all people with the disease the opportunity to lead full, productive lives by funding research and drug development, promoting individualized treatment and ensuring access to high-quality, specialized care.
The Pilot and Feasibility awards are not meant to support continuation of programs begun under other granting mechanisms. These grants are for developing and testing new hypotheses and/or new methods, and to support promising new investigators as they establish themselves in research areas relevant to cystic fibrosis. Proposed work must be hypothesis-driven and must reflect innovative approaches to critical questions in CF research.
Information derived from such studies will hopefully lead to submission to other funding agencies, such as the National Institutes of Health.
Support may be requested for $50,000 per year (plus 8 percent for indirect costs) for two years.
Priority will be placed on those projects that propose to better understand the mechanisms behind disease pathophysiology and to develop strategies to prevent or treat CF.
Please visit the CFF website for further details.
Deadline: April 8, 2016
The Career Development Award, offered by the Lupus Foundation of America, will fund 1 or 2 fellows for a maximum of 2 years. Grant awards are in the amount of up to $70,000 each. The grants will be awarded based on the availability of funds. The fellowship funding may be renewable for a second year of up to an additional $70,000.
The purpose of Foundation’s Career Development Award is to facilitate the professional development of rheumatology, nephrology and dermatology fellows, in the U.S. and Canada, interested in lupus research towards a career as an independent clinician-scientist at an academic, medical, or research institution.
Please visit the Lupus Foundation of America website for further details.
Deadline: April 11, 2016
The ultimate goal of the Cystinosis Research Foundation is a cure for cystinosis. Global calls for grant applications will be made twice each year. Research and fellowship grants are awarded for 1-3 years.
Currently, the Cystinosis Research Foundation has $2,000,000 available for research and fellowship grants. The number of awards and their value will depend on the number of outstanding proposals and the funds available at the time.
The deadline for the spring 2016 grant proposals and fellowship applications is Monday, April 11, 2016. The successful grant applicants will be notified by the end of June, 2016. Please note that the earliest start date for research projects submitted for this cycle is September 1, 2016.
Please visit the CRF website for further details.
LOI Deadline: April 28, 2016
The Department of Defense (DoD) Ovarian Cancer Research Program (OCRP) supports high-impact, cutting-edge research that fills unmet needs. The OCRP establishes priorities to target the most critical needs along the pipeline from basic to translational to clinical research and to push the field of ovarian cancer forward in our vision to eliminate this disease. Our current research priorities include:
- Understanding the precursor lesion/stem cell, microenvironment, and pathogenesis/progression of all types of ovarian cancer including rare subtypes
- Developing or improving performance and reliability of screening, diagnostic approaches, and treatment
- Developing and validating models to study initiation and progression of ovarian cancer
- Addressing issues in primary prevention and survivorship
- Investigating tumor response to therapy including tumor survival, dormancy, cell death, clonal evolution, and tumor heterogeneity
- Enhancing pool of ovarian cancer scientists
Please visit the DoD OCRP website for further details.
AWARDS AND HONOURS:
Nomination Deadline: May 20, 2016
Since its inception in 1945, the Medal of Honour has been awarded to truly outstanding individuals whose research and/or contribution to public policies supportive of research and development in Canada have achieved international recognition.
Nominees must be Canadian residents whose work/research has been performed in Canada and has made a truly notable or pivotal contribution to the advancement of knowledge in the health sciences, health policy and/or the improvement of therapeutics and healthcare. Recipients can originate from a variety of fields and sectors including patient groups, educators, journalists, industry, and the public and non-profit sectors.
The $20,000 prize will be invested back into innovative health research at the Canadian academic institution of the recipient’s choice to promote further life sciences research in Canada.
To submit a nomination for a worthy candidate, please visit our website to access the terms of reference and nomination form: www.hrf-frs.com
UBC Centre for Blood Research Seminar Series – Dr. Sidney Strickland: Connections between Alzheimer’s disease and the cerebrovascular system
Date & Time: March 30, 2016; 12-1pm
Location: LSC 3, Life Sciences Centre, 2350 Health Sciences Mall, Vancouver
Dr. Sidney Strickland
Professor and Head,
Patricia and John Rosenwald Laboratory of Neurobiology and Genetics,
The Rockefeller University
Alzheimer’s disease (AD) is multifactorial and complex, and it is very unlikely that one central mechanism is responsible for its pathogenesis. Vascular abnormalities are often present in AD, and patients with both AD and brain vascular pathology are considered to have “mixed dementia”. Given the prevalence of these overlapping pathologies, a fundamental question arises: Does the coexistence of AD and vascular pathology represent independent co-morbidities, or does the AD-related peptide Aβ interact with components of the vascular system to induce and/or accelerate vascular abnormalities and dementia? My talk will explore the effects Aβ can have on blood coagulation and brain inflammation systems, and the implications of these effects for the pathogenesis, diagnosis and treatment of AD.
Date & Time: April 8, 2016; 9am
Location: University Golf Club, 5185 University Boulevard, Vancouver
Are you interested in developing key strategies for effective, impactful research? identifying resources to support your research? meeting potential collaborators?
The UBC Department of Family Practice invites you to attend a Research Development Workshop.
Plenary Speakers: James McCormack and Maria Hubinette
Register online at: http://tinyurl.com/j3uyrys